Report of Independent Registered Public
Accounting Firm

To the Shareholders and
Board of Trustees of The UBS Funds
In planning and performing our audit of the financial
statements of The UBS Funds (comprising, respectively,
UBS All China Equity Fund, UBS Dynamic Alpha Fund,
UBS Global Allocation Fund, UBS Emerging Markets
Equity Opportunity Fund, UBS Engage For Impact
Fund, UBS International Sustainable Equity Fund, UBS
US Dividend Ruler Fund, UBS US Quality Growth At
Reasonable Price Fund, UBS U.S. Small Cap Growth
Fund, UBS Municipal Bond Fund, UBS Sustainable
Development Bank Bond Fund and UBS Total Return
Bond Fund) (collectively referred to as the "Company"),
as of and for the year ended June 30, 2021, in
accordance with the standards of the Public Company
Accounting Oversight Board (United States) (PCAOB),
we considered the Company's internal control over
financial reporting, including controls over safeguarding
securities, as a basis for designing our auditing
procedures for the purpose of expressing our opinion on
the financial statements and to comply with the
requirements of Form N-CEN, but not for the purpose of
expressing an opinion on the effectiveness of the
Company's internal control over financial reporting.
Accordingly, we express no such opinion.
The management of the Company is responsible for
establishing and maintaining effective internal control
over financial reporting. In fulfilling this responsibility,
estimates and judgments by management are required to
assess the expected benefits and related costs of
controls. A company's internal control over financial
reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting
and the preparation of financial statements for external
purposes in accordance with U.S. generally accepted
accounting principles. A company's internal control
over financial reporting includes those policies and
procedures that (1) pertain to the maintenance of records
that, in reasonable detail, accurately and fairly reflect
the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that
transactions are recorded as necessary to permit
preparation of financial statements in accordance with
U.S. generally accepted accounting principles, and that
receipts and expenditures of the company are being
made only in accordance with authorizations of
management and of the company; and (3) provide
reasonable assurance regarding prevention or timely
detection of unauthorized acquisition, use or disposition
of a company's assets that could have a material effect
on the financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in
conditions, or that the degree of compliance with the
policies or procedures may deteriorate.
A deficiency in internal control over financial reporting
exists when the design or operation of a control does not
allow management or employees, in the normal course
of performing their assigned functions, to prevent or
detect misstatements on a timely basis. A material
weakness is a deficiency, or a combination of
deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material
misstatement of the Company's annual or interim
financial statements will not be prevented or detected on
a timely basis.
Our consideration of the Company's internal control
over financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal control
that might be material weaknesses under standards
established by the PCAOB. However, we noted no
deficiencies in the Company's internal control over
financial reporting and its operation, including controls
over safeguarding securities, that we consider to be a
material weakness as defined above as of June 30, 2021.
This report is intended solely for the information and
use of management and the Board of Trustees of the
UBS Funds and the Securities and Exchange
Commission and is not intended to be and should not be
used by anyone other than these specified parties.

/s/ ERNST & YOUNG LLP
New York, New York
August 27, 2021